Cellectar Biosciences, Inc. Quarterly Nonoperating Income (Expense) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Cellectar Biosciences, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2010 to Q2 2024.
  • Cellectar Biosciences, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $12.8M.
  • Cellectar Biosciences, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was -$5.36M, a 4.83% decline year-over-year.
  • Cellectar Biosciences, Inc. annual Nonoperating Income (Expense) for 2023 was -$3.87M, a 27.4% decline from 2022.
  • Cellectar Biosciences, Inc. annual Nonoperating Income (Expense) for 2022 was -$3.04M, a 34175% decline from 2021.
  • Cellectar Biosciences, Inc. annual Nonoperating Income (Expense) for 2021 was $8.92K, a 95.5% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$5.36M $12.8M +$14.7M Apr 1, 2024 Jun 30, 2024 10-Q 2024-10-29
Q1 2024 -$20M -$14.6M -$16.2M -1066% Jan 1, 2024 Mar 31, 2024 10-Q/A 2024-10-29
Q4 2023 -$3.87M $4.61M +$9.65M Oct 1, 2023 Dec 31, 2023 10-K/A 2024-10-29
Q3 2023 -$13.5M -$8.11M -$8.41M -2765% Jul 1, 2023 Sep 30, 2023 10-K/A 2024-10-29
Q2 2023 -$5.11M -$1.88M -$3.69M -205% Apr 1, 2023 Jun 30, 2023 10-Q 2024-10-29
Q1 2023 -$1.42M $1.51M +$1.61M Jan 1, 2023 Mar 31, 2023 10-Q/A 2024-10-29
Q4 2022 -$3.04M -$5.04M -$5.05M -95143% Oct 1, 2022 Dec 31, 2022 10-K/A 2024-10-29
Q3 2022 $2.01M $304K +$304K +51453% Jul 1, 2022 Sep 30, 2022 10-K/A 2024-10-29
Q2 2022 $1.71M $1.8M +$1.8M +273114% Apr 1, 2022 Jun 30, 2022 10-K/A 2024-10-29
Q1 2022 -$93K -$99.6K -$102K -4315% Jan 1, 2022 Mar 31, 2022 10-K/A 2024-10-29
Q4 2021 $8.92K $5.31K -$179K -97.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 $188K $590 +$216 +57.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $188K $659 -$9.65K -93.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $197K $2.36K +$1.32K +126% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $196K $184K +$180K +3849% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-21
Q3 2020 $16.4K $374 -$59.7K -99.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $76.1K $10.3K -$2.49K -19.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $78.6K $1.05K -$7.12K -87.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $85.7K $4.67K -$52.6K -91.8% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-02
Q3 2019 $138K $60.1K -$12.5K -17.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $151K $12.8K +$28.6K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $122K $8.17K +$30.5K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $91.7K $57.2K +$47.5K +487% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-09
Q3 2018 $44.2K $72.6K +$59.5K +455% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$15.2K -$15.8K -$111K -117% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 $95.5K -$22.3K +$56.8K +71.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-06
Q4 2017 $38.7K $9.76K -$53.4K -84.5% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-26
Q3 2017 $92K $13.1K -$168K -92.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 $260K $94.9K -$105K -52.5% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 $365K -$79.1K -$2.9M -103% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 $3.27M $63.1K -$2.67M -97.7% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-21
Q3 2016 $5.94M $181K -$53.2K -22.7% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $6M $200K +$195K +4274% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 $5.8M $2.83M +$2.54M +887% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 $3.26M $2.74M +$3.83M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-15
Q3 2015 -$569K $234K -$2.36M -91% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $1.79M $4.57K -$455K -99% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 $2.25M $286K +$410K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 $1.84M -$1.09M -$1.2M -1113% Oct 1, 2014 Dec 31, 2014 10-K/A 2016-10-20
Q3 2014 $3.04M $2.6M +$1M +62.8% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 $2.04M $460K -$198K -30.1% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-12
Q1 2014 $2.24M -$124K +$617K +83.3% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-20
Q4 2013 $1.62M $108K +$102K +1633% Oct 1, 2013 Dec 31, 2013 10-K/A 2015-05-20
Q3 2013 $1.52M $1.6M +$1.59M +88224% Jul 1, 2013 Sep 30, 2013 10-Q/A 2015-05-20
Q2 2013 -$75.4K $658K +$677K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-04
Q1 2013 -$753K -$742K -$711K -2298% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 -$42.2K $6.23K -$46.4K -88.2% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-19
Q3 2012 $4.23K $1.81K -$298 -14.2% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-13
Q2 2012 $4.53K -$19.3K +$321K +94.3% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-12
Q1 2012 -$317K -$30.9K +$80.8K +72.3% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$398K $52.7K Oct 1, 2011 Dec 31, 2011 10-K 2013-03-28
Q3 2011 $2.1K +$95.2K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 -$341K -$249K -273% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 -$112K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-04
Q3 2010 -$93.1K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-07
Q2 2010 -$91.4K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.